Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S0VZ
|
|||
| Former ID |
DIB000663
|
|||
| Drug Name |
IDRA-21
|
|||
| Synonyms |
IDRA-21 analogs; IDRA-5
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Terminated | [1], [2] | |
| Company |
Fidia-Georgetown Institute for the Neurosciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H9ClN2O2S
|
|||
| Canonical SMILES |
CC1NC2=C(C=C(C=C2)Cl)S(=O)(=O)N1
|
|||
| InChI |
1S/C8H9ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-5,10-11H,1H3
|
|||
| InChIKey |
VZRNTCHTJRLTMU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 22503-72-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3153204, 4725772, 8152331, 14798209, 24896078, 26752113, 29222811, 47211774, 47959889, 57321941, 75096882, 85787797, 91704602, 103277548, 103807507, 104304235, 117464560, 118696386, 126407681, 129550235, 135116603, 135156569, 135156570, 135698080, 137102587, 142978078, 143857868, 162022823, 162227378, 162817920, 178101036, 184590059, 226553987, 241182241, 241375306, 252451275
|
|||
| ChEBI ID |
CHEBI:111162
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate receptor AMPA (GRIA) | Target Info | Modulator | [2] |
| N-methyl-D-aspartate receptor (NMDAR) | Target Info | Modulator | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4219). | |||
| REF 2 | IDRA-21, a positive AMPA receptor modulator, inhibits synaptic and extrasynaptic NMDA receptor mediated events in cultured cerebellar granule cells. Neuropharmacology. 2004 Jun;46(8):1105-13. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.